Related Articles
EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients
EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl‑2
A novel alternative splicing isoform of NF2 identified in human Schwann cells
EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β‑catenin/E‑cadherin pathway
Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2